Mesoblast (MESO) Return on Invested Capital (2018 - 2023)
Mesoblast recorded quarterly Return on Invested Capital of 0.03% in Q2 2023, up 4.86% quarter-over-quarter from 0.03% in Q1 2023, and up 1.0% year-over-year from 0.03% in Q2 2022.
Mesoblast's Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.03% for Q2 2023.
- In Q2 2023, Return on Invested Capital rose 1.0% year-over-year to 0.03%; the TTM figure through Jun 2023 stood at 0.03% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital came in at 0.03% for Q2 2023 at Mesoblast, up from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.19% in Q1 2022 to a low of 0.11% in Q1 2019.
- A 5-year average of 0.0% and a median of 0.03% in 2022 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital advanced 16 bps in 2022 and retreated 22 bps in 2023, its largest moves.
- Mesoblast's Return on Invested Capital stood at 0.08% in 2019, then soared by 150 bps to 0.04% in 2020, then jumped by 277 bps to 0.15% in 2021, then sank by 123 bps to 0.03% in 2022, then rose by 3 bps to 0.03% in 2023.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.03%, 0.03%, and 0.03% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.01% |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.05% |
| Mar 31, 2022 | 0.19% |
| Dec 31, 2021 | 0.15% |
| Sep 30, 2021 | 0.10% |
| Jun 30, 2021 | 0.13% |
| Mar 31, 2021 | 0.02% |
| Dec 31, 2020 | 0.04% |
| Sep 30, 2020 | 0.01% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | -0.10% |
| Dec 31, 2019 | -0.08% |
| Sep 30, 2019 | -0.05% |
| Jun 30, 2019 | -0.06% |
| Mar 31, 2019 | -0.11% |
| Dec 31, 2018 | -0.18% |
| Sep 30, 2018 | -0.11% |
| Jun 30, 2018 | -0.10% |